LongueVue Capital and Swaney Group Capital Recapitalize Apex Dental Laboratory Group
Event summary
- LongueVue Capital and Swaney Group Capital completed a majority recapitalization of Apex Dental Laboratory Group on March 31, 2026.
- Apex operates 16 labs across 10 states and has grown through 22 acquisitions and 3 de novo openings.
- Billy Braun, former CEO of DDS Lab, joins Apex as Executive Chairman.
- Apex's management team remains intact, with Kay Hayden and Travis Zick continuing their leadership roles.
The big picture
This recapitalization reflects the ongoing consolidation trend in the dental laboratory sector, driven by private equity firms seeking to scale platforms with established regional footprints. Apex's focus on U.S.-manufactured products positions it uniquely in a market where supply chain resilience is increasingly valued. The involvement of industry veteran Billy Braun suggests a strategic emphasis on operational excellence and potential expansion.
What we're watching
- Consolidation Strategy
- Whether LongueVue Capital and Swaney Group Capital will accelerate Apex's acquisition pace to expand its national footprint.
- Operational Integration
- How Billy Braun's industry experience will influence Apex's strategic direction and operational efficiency.
- Made in America Focus
- The competitive advantage of Apex's U.S.-manufactured products in an increasingly globalized dental laboratory market.